173 related articles for article (PubMed ID: 7521411)
1. [Specific antibody assay for genotyping of hepatitis C virus].
Kohara M
Nihon Rinsho; 1994 Jul; 52(7):1728-33. PubMed ID: 7521411
[TBL] [Abstract][Full Text] [Related]
2. Significance of specific antibody assay for genotyping of hepatitis C virus.
Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
[TBL] [Abstract][Full Text] [Related]
3. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
[TBL] [Abstract][Full Text] [Related]
4. [Antigenicities of groups I and II hepatitis C virus].
Kohara M
Nihon Rinsho; 1993 Feb; 51(2):338-43. PubMed ID: 7681884
[TBL] [Abstract][Full Text] [Related]
5. Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b.
Saito T; Ito T; Ishiko H; Yonaha M; Morikawa K; Miyokawa A; Mitamura K
Am J Gastroenterol; 2003 Jun; 98(6):1377-83. PubMed ID: 12818284
[TBL] [Abstract][Full Text] [Related]
6. Sequence analysis of hepatitis C virus variants producing discrepant results with two different genotyping assays.
Prescott LE; Berger A; Pawlotsky JM; Conjeevaram P; Pike I; Simmonds P
J Med Virol; 1997 Nov; 53(3):237-44. PubMed ID: 9365889
[TBL] [Abstract][Full Text] [Related]
7. Study of hepatitis C virus genotype in Guizhou area of southwestern China.
Ding J; Akira T; Noriko Y; Mikihiro T; Takayasu D
Chin Med J (Engl); 1998 Feb; 111(2):128-31. PubMed ID: 10374371
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
Zeuzem S; Lee JH; Roth WK
Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
[TBL] [Abstract][Full Text] [Related]
9. Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong.
Prescott LE; Simmonds P; Lai CL; Chan NK; Pike I; Yap PL; Lin CK
J Med Virol; 1996 Oct; 50(2):168-75. PubMed ID: 8915883
[TBL] [Abstract][Full Text] [Related]
10. Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes.
Frangeul L; Cresta P; Perrin M; Lunel F; Opolon P; Agut H; Huraux JM
Hepatology; 1998 Dec; 28(6):1674-9. PubMed ID: 9828234
[TBL] [Abstract][Full Text] [Related]
11. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
[TBL] [Abstract][Full Text] [Related]
12. Type-specific antibody for hepatitis C virus detected by use of NS-4 peptide and hepatitis C virus genome in Korea.
Son HC; Yoon MS; Kim YJ; Kim IH; Kim YS
Rinsho Byori; 2002 May; 50(5):533-40. PubMed ID: 12078055
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of two hepatitis C virus typing assays in a Tunisian population].
Ben Moussa M; Barguellil F; Bouziani A; Amor A
Ann Biol Clin (Paris); 2003; 61(2):234-8. PubMed ID: 12702482
[TBL] [Abstract][Full Text] [Related]
14. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C in northern Estonia.
Tallo T; Lappalainen M; Tefanova V; Priimägi I
Acta Virol; 2000; 44(3):175-8. PubMed ID: 11155361
[TBL] [Abstract][Full Text] [Related]
15. Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
Lodrini S; Bagaglio S; Canducci F; De Mitri MS; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G
J Biol Regul Homeost Agents; 2003; 17(2):198-204. PubMed ID: 14518724
[TBL] [Abstract][Full Text] [Related]
16. [HCV-serotype and IFN response].
Nakamura H; Kako M; Aikawa T; Mayumi M; Kanai K
Nihon Rinsho; 1994 Jul; 52(7):1734-7. PubMed ID: 7521412
[TBL] [Abstract][Full Text] [Related]
17. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
18. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).
Hadlock KG; Gish R; Rowe J; Rajyaguru SS; Newsom M; Warford A; Foung SK
J Med Virol; 2001 Sep; 65(1):23-9. PubMed ID: 11505439
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection.
Yuki N; Hayashi N; Kasahara A; Hagiwara H; Mita E; Ohkawa K; Katayama K; Fusamoto H; Kamada T
Hepatology; 1996 May; 23(5):947-52. PubMed ID: 8621173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]